O. Peschard

发表

Reduction of Hair-loss: Matrikines and plant molecules to the rescue

F. Lamy, P. Mondon, C. Mas-Chamberlin, 2004 .

Inhibitors of tripeptidyl peptidase II. 2. Generation of the first novel lead inhibitor of cholecystokinin-8-inactivating peptidase: a strategy for the design of peptidase inhibitors.

J. Schwartz, P. B. Bishop, O. Peschard, 2000, Journal of medicinal chemistry.

Enantioselective electrophilic bond construction to the α-carbon of α-aminoacids

O. Peschard, A. Ravard, J. Valnot, 1988 .

Cyclization of methyl α-bromocrotonate to a pentasubstituted cyclopropane

O. Peschard, G. Plé, L. Duhamel, 1991 .

Cosmeceuticals and active ingredients.

P. Mondon, O. Peschard, K. Lintner, 2009, Clinics in dermatology.

Di-acetyl-nor-aporphines: Novel molecules and novel mechanism to inhibit melanogenesis

F. Lamy, P. Mondon, O. Peschard, 2004 .

A new matrikine‐derived peptide up‐regulates longevity genes for improving extracellular matrix architecture and connections of dermal cell with its matrix

P. Mondon, O. Peschard, C. Ringenbach, 2020, International journal of cosmetic science.

Evaluation of dermal extracellular matrix and epidermal–dermal junction modifications using matrix‐assisted laser desorption/ionization mass spectrometric imaging, in vivo reflectance confocal microscopy, echography, and histology: effect of age and peptide applications

P. Mondon, O. Peschard, Solenne Chardonnet, 2015, Journal of cosmetic dermatology.

Development of a multiparametric in vitro model of skin sensitization

Wilfried Veron, P. Mondon, O. Peschard, 2015, Journal of applied toxicology : JAT.

Novel in-silico predicted matrikines are differential mediators of in vitro and in vivo cellular metabolism

L. Debelle, A. Gilmore, P. Mondon, 2023, bioRxiv.